Endothelial Dysfunction and Hypertension

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)

James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950

Origin and physiological roles of inflammation

Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618

Vascular endothelial cells synthesize nitric oxide from L-arginine

Palmer, R. M. J., Ashton, D. S., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,769

Endothelial Dysfunction: A Marker of Atherosclerotic Risk

Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,200

Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues.

Dawson, T. M., Bredt, D. S., Fotuhi, M., Hwang, P. M., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7797 · Cited by 1,843

The Vascular Endothelium and Human Diseases

Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., & Nishigaki, I. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.7502 · Cited by 1,467

Endothelial Dysfunction

Endemann, D. H., & Schiffrin, E. L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000132474.50966.da · Cited by 1,198

How Common Is White Coat Hypertension?

Pickering, T. G. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720020027031 · Cited by 1,190

cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action

Francis, S. H., Busch, J. L., & Corbin, J. D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002907 · Cited by 1,028

Molecular basis of the effects of shear stress on vascular endothelial cells

Li, Y.-S. J., Haga, J. H., & Chien, S. (2005) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2004.09.030 · Cited by 904

The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)

Siti, H. N., Kamisah, Y., & Kamsiah, J. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.03.005 · Cited by 898

Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

Lüscher, T. F., & Vanhoutte, P. M. (1986) · Hypertension · doi:10.1161/01.hyp.8.4.344 · Cited by 878

Vascular nitric oxide: Beyond eNOS

Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 826

Endothelial dysfunction and vascular disease

Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Feletou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 806

Endothelin

Davenport, A. P., Hyndman, K. A., Dhaun, N., Southan, C., Kohan, D. E., Pollock, J. S., Pollock, D. M., Webb, D. J., & Maguire, J. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011833 · Cited by 772

LOX-1, OxLDL, and Atherosclerosis

Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 769

Endothelin System: The Double-Edged Sword in Health and Disease

Kedzierski, R. M., & Yanagisawa, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.851 · Cited by 745

New Markers of Inflammation and Endothelial Cell Activation: Part I

Szmitko, P. E., Wang, C.-H., Weisel, R. D., de Almeida, J. R., Anderson, T. J., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000089190.95415.9f · Cited by 738

Oxidative stress in angiogenesis and vascular disease

Kim, Y.-W., & Byzova, T. V. (2014) · Blood · doi:10.1182/blood-2013-09-512749 · Cited by 701

Endothelial cell control of thrombosis

Yau, J. W., Teoh, H., & Verma, S. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0124-z · Cited by 691

Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension

Weber, M. A., Schiffrin, E. L., White, W. B., Mann, S., Lindholm, L. H., Kenerson, J. G., Flack, J. M., Carter, B. L., Materson, B. J., Ram, C. V. S., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000065 · Cited by 683

Pathogenesis of Hypertension

Oparil, S., Zaman, M. A., & Calhoun, D. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-9-200311040-00011 · Cited by 680

The significance of OX40 and OX40L to T‐cell biology and immune disease

Croft, M., So, T., Duan, W., & Soroosh, P. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00766.x · Cited by 604

The Effect of an Endothelin-Receptor Antagonist, Bosentan, on Blood Pressure in Patients with Essential Hypertension

Krum, H., Viskoper, R. J., Lacourciere, Y., Budde, M., & Charlon, V. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803193381202 · Cited by 570

Extracellular vesicles in physiological and pathological conditions

Yuana, Y., Sturk, A., & Nieuwland, R. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.002 · Cited by 569

Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells

Liu, Z., & Roche, P. A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00001 · Cited by 559

Role of insulin resistance in endothelial dysfunction

Muniyappa, R., & Sowers, J. R. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9229-1 · Cited by 539

Vascular endothelium – Gatekeeper of vessel health

Cahill, P. A., & Redmond, E. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.007 · Cited by 518

Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction

Boulanger, C. M., Scoazec, A., Ebrahimian, T., Henry, P., Mathieu, E., Tedgui, A., & Mallat, Z. (2001) · Circulation · doi:10.1161/hc4701.100516 · Cited by 510

Effects of Severe Hypertension on Endothelial and Platelet Microparticles

Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M., Aime, G., & Ahn, Y. S. (2003) · Hypertension · doi:10.1161/01.hyp.0000049760.15764.2d · Cited by 499

Endothelium-Derived Hyperpolarizing Factor: Where Are We Now?

Félétou, M., & Vanhoutte, P. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000217611.81085.c5 · Cited by 488

Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis

Fagard, R. H., & Cornelissen, V. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282ef6185 · Cited by 480

Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications

Steffel, J., Lüscher, T. F., & Tanner, F. C. (2006) · Circulation · doi:10.1161/circulationaha.105.567297 · Cited by 456

The Role of Monocytes in Angiogenesis and Atherosclerosis

Jaipersad, A. S., Lip, G. Y. H., Silverman, S., & Shantsila, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.019 · Cited by 451

High levels of circulating endothelial microparticles in patients with acute coronary syndromes

Bernal-Mizrachi, L., Jy, W., Jimenez, J. J., Pastor, J., Mauro, L. M., Horstman, L. L., de Marchena, E., & Ahn, Y. S. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00103-0 · Cited by 441

Shear stress and the endothelium

Ballermann, B. J., Dardik, A., Eng, E., & Liu, A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06720.x · Cited by 439

An evolving new paradigm: endothelial cells – conditional innate immune cells

Mai, J., Virtue, A., Shen, J., Wang, H., & Yang, X.-F. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-61 · Cited by 433

Wall Shear Stress – an Important Determinant of Endothelial Cell Function and Structure – in the Arterial System in vivo

Reneman, R. S., Arts, T., & Hoeks, A. P. G. (2006) · Journal of Vascular Research · doi:10.1159/000091648 · Cited by 431

Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets

Jiang, F., Yang, J., Zhang, Y., Dong, M., Wang, S., Zhang, Q., Liu, F. F., Zhang, K., & Zhang, C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.59 · Cited by 426

Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature: A Potential Link Between the Renin-Angiotensin System and Atherosclerosis

Tummala, P. E., Chen, X.-L., Sundell, C. L., Laursen, J. B., Hammes, C. P., Alexander, R. W., Harrison, D. G., & Medford, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1223 · Cited by 379

Average Daily Blood Pressure, Not Office Blood Pressure, Determines Cardiac Function in Patients With Hypertension

White, W. B. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420060089038 · Cited by 364

Endothelial Function in Hypertension: The Role of Superoxide Anion

McIntyre, M., Bohr, D. F., & Dominiczak, A. F. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.539 · Cited by 354

Prognostic Value of White-Coat and Masked Hypertension Diagnosed by Ambulatory Monitoring in Initially Untreated Subjects: An Updated Meta Analysis

Pierdomenico, S. D., & Cuccurullo, F. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2010.203 · Cited by 349

Oxidative Stress and Human Hypertension: Vascular Mechanisms, Biomarkers, and Novel Therapies

Montezano, A. C., Dulak-Lis, M., Tsiropoulou, S., Harvey, A., Briones, A. M., & Touyz, R. M. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.008 · Cited by 323

Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension: A Randomized, Double-Blind, Crossover Study

Tzemos, N., Lim, P. O., & MacDonald, T. M. (2001) · Circulation · doi:10.1161/hc3001.094207 · Cited by 317

Prognosis of White-Coat and Masked Hypertension: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome

Stergiou, G. S., Asayama, K., Thijs, L., Kollias, A., Niiranen, T. J., Hozawa, A., Boggia, J., Johansson, J. K., Ohkubo, T., Tsuji, I., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02741 · Cited by 304

Cellular signaling and NO production

Michel, T., & Vanhoutte, P. M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0765-9 · Cited by 287

Immunosenescent CD8 + T Cells and C-X-C Chemokine Receptor Type 3 Chemokines Are Increased in Human Hypertension

Youn, J.-C., Yu, H. T., Lim, B. J., Koh, M. J., Lee, J., Chang, D.-Y., Choi, Y. S., Lee, S.-H., Kang, S.-M., Jang, Y., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00689 · Cited by 284

Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

Chappell, M. C. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2015 · Cited by 280

Role of endothelial dysfunction in insulin resistance

Hsueh, W. A., & Quiñones, M. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00611-8 · Cited by 276

"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.

Julius, S., Mejia, A., Jones, K., Krause, L., Schork, N., van de Ven, C., Johnson, E., Petrin, J., Sekkarie, M. A., & Kjeldsen, S. E. (1990) · Hypertension · doi:10.1161/01.hyp.16.6.617 · Cited by 272

Systems Biology of Free Radicals and Antioxidants

(2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9 · Cited by 268

Atherosclerosis as an Inflammatory Disease

Tuttolomondo, A., Di Raimondo, D., Pecoraro, R., Arnao, V., Pinto, A., & Licata, G. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802481237 · Cited by 257

Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide

Pushpakumar, S., Kundu, S., & Sen, U. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140706142335 · Cited by 256

Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension.

Dohi, Y., Thiel, M. A., Bühler, F. R., & Lüscher, T. F. (1990) · Hypertension · doi:10.1161/01.hyp.16.2.170 · Cited by 252

Endothelial Barrier and Its Abnormalities in Cardiovascular Disease

Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00365 · Cited by 250

Inflammation and the Activated Protein C Anticoagulant Pathway

Esmon, C. (2006) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2006-939554 · Cited by 249

Intact and altered endothelium in regulation of vasomotion.

Lerman, A., & Burnett, J. C. J. (1992) · PubMed · Cited by 247

Vascular endothelial dysfunction and pharmacological treatment

Su, J. B. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i11.719 · Cited by 238

Relationship between Oxidative Stress and Essential Hypertension

RODRIGO, R., PRAT, H., PASSALACQUA, W., ARAYA, J., GUICHARD, C., & BÄCHLER, J. P. (2007) · Hypertension Research · doi:10.1291/hypres.30.1159 · Cited by 235

iNOS (NOS2) at a glance

Lowenstein, C. J., & Padalko, E. (2004) · Journal of Cell Science · doi:10.1242/jcs.01166 · Cited by 233

Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations

Lee, R., Margaritis, M., M. Channon, K., & Antoniades, C. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800493057 · Cited by 232

Oxidized LDL Induces Alternative Macrophage Phenotype through Activation of CD36 and PAFR

Rios, F. J., Koga, M. M., Pecenin, M., Ferracini, M., Gidlund, M., & Jancar, S. (2013) · Mediators of Inflammation · doi:10.1155/2013/198193 · Cited by 232

Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin

Kellogg, D. L., Zhao, J. L., Coey, U., & Green, J. V. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00728.2004 · Cited by 219

Possible role of oxidative stress in the pathogenesis of hypertension

Ceriello, A. (2008) · Diabetes Care · doi:10.2337/dc08-s245 · Cited by 215

Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets

De Miguel, C., Rudemiller, N. P., Abais, J. M., & Mattson, D. L. (2015) · Current Hypertension Reports · doi:10.1007/s11906-014-0507-z · Cited by 215

Oxidative Stress-Related Biomarkers in Essential Hypertension and Ischemia-Reperfusion Myocardial Damage

Rodrigo, R., Libuy, M., Feliú, F., & Hasson, D. (2013) · Disease Markers · doi:10.1155/2013/974358 · Cited by 209

Immune Mechanisms in Arterial Hypertension

Wenzel, U., Turner, J. E., Krebs, C., Kurts, C., Harrison, D. G., & Ehmke, H. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050562 · Cited by 205

Oxidative Stress in Leukocytes Is a Possible Link Between Blood Pressure, Blood Glucose, and C-Reacting Protein

Yasunari, K., Maeda, K., Nakamura, M., & Yoshikawa, J. (2002) · Hypertension · doi:10.1161/hy0302.104670 · Cited by 200

Essential hypertension and oxidative stress: New insights

González, J. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i6.353 · Cited by 196

Acute and Chronic Angiotensin-1 Receptor Antagonism Reverses Endothelial Dysfunction in Atherosclerosis

Prasad, A., Tupas-Habib, T., Schenke, W. H., Mincemoyer, R., Panza, J. A., Waclawin, M. A., Ellahham, S., & Quyyumi, A. A. (2000) · Circulation · doi:10.1161/01.cir.101.20.2349 · Cited by 196

The Cooperative Roles of Inflammation and Oxidative Stress in the Pathogenesis of Hypertension

Crowley, S. D. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5258 · Cited by 191

Endothelial Dysfunction, Obesity and Insulin Resistance

Prieto, D., Contreras, C., & Sanchez, A. (2014) · Current Vascular Pharmacology · doi:10.2174/1570161112666140423221008 · Cited by 190

Vascular endottielial cell proliferation in culture and the influence of flow

Levesque, M. J., Nerem, R. M., & Sprague, E. A. (1990) · Biomaterials · doi:10.1016/0142-9612(90)90031-k · Cited by 189

Homocysteine and the pathogenesis of atherosclerosis

McCully, K. S. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1010516 · Cited by 185

Significance of White-Coat Hypertension in Older Persons With Isolated Systolic Hypertension: A Meta-Analysis Using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Population

Franklin, S. S., Thijs, L., Hansen, T. W., Li, Y., Boggia, J., Kikuya, M., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.180653 · Cited by 184

Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease

Luksha, L., Agewall, S., & Kublickiene, K. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.008 · Cited by 181

Nitric oxide and cardiovascular control

Calver, A., Collier, J., & Vallance, P. (1993) · Experimental Physiology · doi:10.1113/expphysiol.1993.sp003687 · Cited by 174

Obesity-related hypertension: possible pathophysiological mechanisms

Vaněčková, I., Maletínská, L., Behuliak, M., Nagelová, V., Zicha, J., & Kuneš, J. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0368 · Cited by 161

ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension

Mendoza‐Torres, E., Oyarzún, A. P., Mondaca‐Ruff, D., Azócar, A. A., Castro, P., Jalil, J., Chiong, M., Lavandero, S., & Ocaranza, M. P. (2015) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944715597623 · Cited by 160

The role of endothelial cell apoptosis in inflammatory and immune diseases

Winn, R. K., & Harlan, J. M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01378.x · Cited by 159

White-coat hypertension and cardiovascular events: a meta-analysis

Briasoulis, A., Androulakis, E., Palla, M., Papageorgiou, N., & Tousoulis, D. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000832 · Cited by 159

Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane‐mediated thromboxane A 2receptor activation

Bauer, J., Ripperger, A., Frantz, S., Ergün, S., Schwedhelm, E., & Benndorf, R. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12677 · Cited by 154

Neuronal nitric oxide synthase and human vascular regulation

Melikian, N., Seddon, M. D., Casadei, B., Chowienczyk, P. J., & Shah, A. M. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2010.02.007 · Cited by 151

Fasting Therapy for Treating and Preventing Disease - Current State of Evidence

Michalsen, A., & Li, C. (2013) · Complementary Medicine Research · doi:10.1159/000357765 · Cited by 148

Nitrate-Nitrite-Nitric Oxide Pathway: Implications for Anesthesiology and Intensive Care

Weitzberg, E., Hezel, M., Lundberg, J. O., & Warner, D. S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181fcf3cc · Cited by 145

The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease

Dunn, S. R., Vohra, R., Murphy, J. E., Homer‐Vanniasinkam, S., Walker, J. H., & Ponnambalam, S. (2007) · Biochemical Journal · doi:10.1042/bj20071196 · Cited by 145

Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension.

Høegholm, A., Bang, L. E., Kristensen, K., Nielsen, J., & Holm, J. (1994) · Hypertension · doi:10.1161/01.hyp.24.1.101 · Cited by 145

Oxidative stress in chronic vascular disease: From prediction to prevention

Santilli, F., D’Ardes, D., & Davì, G. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.09.003 · Cited by 143

Mechanisms of Inducible Nitric Oxide Synthase–Mediated Vascular Dysfunction

Gunnett, C. A., Lund, D. D., McDowell, A. K., Faraci, F. M., & Heistad, D. D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000172626.00296.ba · Cited by 141

Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis

Stancel, N., Chen, C.-C., Ke, L., Chu, C., Lu, J., Sawamura, T., & Chen, C. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.243923 · Cited by 137

Endothelial dysfunction and oxidative stress in arterial hypertension

Ferroni, P., Basili, S., Paoletti, V., & Davì, G. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.11.012 · Cited by 134

AT2 Receptor Activities and Pathophysiological Implications

Matavelli, L. C., & Siragy, H. M. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000208 · Cited by 130

Leptin and the regulation of endothelial function in physiological and pathological conditions

Bełtowski, J. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05623.x · Cited by 129

Relevance of endothelial junctions in leukocyte extravasation and vascular permeability

Vestweber, D. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06558.x · Cited by 128

Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.

Ferri, C., Desideri, G., Baldoncini, R., Bellini, C., Angelis, C. D., Mazzocchi, C., & Santucci, A. (1998) · Diabetes · doi:10.2337/diabetes.47.4.660 · Cited by 127

Atrial natriuretic factor prevents NaCl-sensitive hypertension in spontaneously hypertensive rats.

Jin, H., Yang, R., Chen, Y., & Oparil, S. (1990) · Hypertension · doi:10.1161/01.hyp.15.2.170 · Cited by 122

Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II

Virdis, A., Duranti, E., & Taddei, S. (2011) · International Journal of Hypertension · doi:10.4061/2011/916310 · Cited by 121

Diagnosis of mild hypertension by ambulatory blood pressure monitoring.

Weber, M. A., Neutel, J. M., Smith, D. H. G., & Graettinger, W. F. (1994) · Circulation · doi:10.1161/01.cir.90.5.2291 · Cited by 120

Different Metabolic Predictors of White-Coat and Sustained Hypertension Over a 20-Year Follow-Up Period

Björklund‐Bodegârd, K., Lind, L., Vessby, B. O., Andrén, B., & Lithell, H. (2002) · Circulation · doi:10.1161/01.cir.0000019737.87850.5a · Cited by 116

Endothelium in hemostasis and thrombosis

Lijnen, H. R., & Collen, D. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80032-1 · Cited by 112

Angiotensin‐(1‐7): Pharmacology and New Perspectives in Cardiovascular Treatments

Trask, A. J., & Ferrario, C. M. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00012.x · Cited by 112

Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension.

Cardillo, C., Felice, F. D., Campia, U., & Folli, G. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.836 · Cited by 112

Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway

Bae, S. W., Kim, H. S., Nam, Y., Park, Y. S., Jo, S. A., & Jo, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01086-6 · Cited by 107

Role of NADPH Oxidase in Endothelial Ischemia/Reperfusion Injury in Humans

Loukogeorgakis, S., van den Berg, J. M., Sofat, R., Nitsch, D., Charakida, M., Haiyee, B., de Groot, E., MacAllister, R. J., Kuijpers, T. W., & Deanfield, J. E. (2010) · Circulation · doi:10.1161/circulationaha.108.814731 · Cited by 104

Activation of the ACE2/Angiotensin-(1–7)/Mas Receptor Axis Enhances the Reparative Function of Dysfunctional Diabetic Endothelial Progenitors

Jarajapu, Y. P. R., Bhatwadekar, A. D., Caballero, S., Hazra, S., Shenoy, V., Medina, R. J., Kent, D., Stitt, A. W., Thut, C. J., Finney, E. M., et al. (2012) · Diabetes · doi:10.2337/db12-0808 · Cited by 104

Vascular endothelial function in health and diseases

Khazaei, M., Moien‐Afshari, F., & Laher, I. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.02.002 · Cited by 102

Purinergic transmission in blood vessels

Ralevic, V., & Dunn, W. R. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.04.007 · Cited by 100

White-coat hypertension

Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., & Porcellati, C. (1996) · The Lancet · doi:10.1016/s0140-6736(04)70084-7 · Cited by 98

Regulatory T Cells and Atherosclerosis

Lopez‐Pastrana, J. (2013) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.s12-002 · Cited by 98

Dual opposing roles of adaptive immunity in hypertension

Idris-Khodja, N., Mian, M. O. R., Paradis, P., & Schiffrin, E. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu119 · Cited by 94

Redox signaling, Nox5 and vascular remodeling in hypertension

Montezano, A. C., Tsiropoulou, S., Dulak-Lis, M., Harvey, A., Camargo, L. D. L., & Touyz, R. M. (2015) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0000000000000153 · Cited by 93

Angiotensin II Stimulates Endothelial NO Synthase Phosphorylation in Thoracic Aorta of Mice With Abdominal Aortic Banding Via Type 2 Receptor

Yayama, K., Hiyoshi, H., Imazu, D., & Okamoto, H. (2006) · Hypertension · doi:10.1161/01.hyp.0000244108.30909.27 · Cited by 93

Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system

Löscher, T. (1991) · European Heart Journal · doi:10.1093/eurheartj/12.suppl_e.2 · Cited by 92

Autoimmunity in the pathogenesis of hypertension

Rodríguez‐Iturbe, B., Pons, H., Quiroz, Y., Lanaspa, M. A., & Johnson, R. J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.248 · Cited by 90

Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: Comparative effects of amlodipine and valsartan

Celık, T., Balta, Ş., Karaman, M., Ay, S. A., Demırkol, S., Öztürk, C., Dinç, M., Ünal, H. U., Yılmaz, M. I., Kılıç, S., et al. (2014) · Blood Pressure · doi:10.3109/08037051.2014.972816 · Cited by 89

White coat effect, blood pressure and mortality in men: prospective cohort study

Strandberg, T. E., & Salomaa, V. (2000) · European Heart Journal · doi:10.1053/euhj.1999.2042 · Cited by 87

Diagnosis and Treatment of Endothelial Dysfunction in Cardiovascular Disease A Review

Hirata, Y., Nagata, D., Suzuki, E., Nishimatsu, H., Suzuki, J., & Nagai, R. (2010) · International Heart Journal · doi:10.1536/ihj.51.1 · Cited by 86

White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis

Cuspidi, C., Rescaldani, M., Tadić, M., Sala, C., Grassi, G. M., & Mancia, G. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000416 · Cited by 86

Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension

Cengız, M., Yavuzer, S., Avcı, B. K., Yürüyen, M., Yavuzer, H., Dikici, A. S., Karataş, Ö. F., Özen, M., Uzun, H., & Öngen, Z. (2015) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2015.1036064 · Cited by 84

Effect of Enalapril on Endothelial Function in Young Insulin-Dependent Diabetic Patients: A Randomized, Double-Blind Study 11This study was supported by a grant from Merck Sharp and Dohme Ltd., Hertfordshire, England, United Kingdom. Ms. Donald is supported by a grant from the Coronary Artery Disease Research Foundation (CORDA), London, England, United Kingdom.

Mullen, M. J., Clarkson, P., Donald, A. E., Thomson, H., Thorne, S., Powe, A. J., Furuno, T., Bull, T., & Deanfield, J. E. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00099-0 · Cited by 80

Cyclooxygenase pathways.

Korbecki, J., Baranowska‐Bosiacka, I., Gutowska, I., et al. (2014) · Acta Biochimica Polonica · doi:10.18388/abp.2014_1825 · Cited by 80

The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension.

Ahmad, A., Singhal, U., Hossain, M. M., Islam, N., & Rizvi, I. (2013) · Journal of clinical and diagnostic research : JCDR · doi:10.7860/jcdr/2013/5829.3091 · Cited by 79

Obesity and Insulin Resistance in Resistant Hypertension: Implications for the Kidney

Rao, A., Pandya, V., & Whaley‐Connell, A. T. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.12.004 · Cited by 78

Nox1 in cardiovascular diseases: regulation and pathophysiology

Gimenez, M., Schickling, B., Lopes, L. R., & Miller, F. J. (2015) · Clinical Science · doi:10.1042/cs20150404 · Cited by 77

Shear stress promotes nitric oxide production in endothelial cells by sub-cellular delocalization of eNOS: A basis for shear stress mediated angiogenesis

Kolluru, G. K., Sinha, S., Majumder, S., Muley, A., Siamwala, J. H., Gupta, R., & Chatterjee, S. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.02.004 · Cited by 76

Nitric Oxide and Malondialdehyde in Human Hypertension

Armas-Padilla, M. C., Armas-Hernández, M. J., Sosa-Canache, B., Cammarata, R., Pacheco, B., Guerrero, J., Carvajal, A. R., Hernández-Hernández, R., Israili, Z., & Valasco, M. (2007) · American Journal of Therapeutics · doi:10.1097/01.pap.0000249914.75895.48 · Cited by 74

Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors

Hlubocká, Z., Umnerová, V., Heller, S., Peleska, J., Jindra, A., Jáchymová, M., Kvasnička, J., Horký, K., & Aschermann, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001403 · Cited by 71

Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young Black and White women

Block, G., Jensen, C. D., Norkus, E. P., Hudes, M. L., & Crawford, P. B. (2008) · Nutrition Journal · doi:10.1186/1475-2891-7-35 · Cited by 67

Biomarkers of lipid peroxidation related to hypertension in aging

Yavuzer, H., Yavuzer, S., Cengiz, M., Erman, H., Doventas, A., Balci, H., Erdincler, D. S., & Uzun, H. (2016) · Hypertension Research · doi:10.1038/hr.2015.156 · Cited by 67

Role of microparticles in endothelial dysfunction and arterial hypertension

Helbing, T. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i11.1135 · Cited by 66

Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion.

Lüscher, T. F., Yang, Z., Diederich, D. A., et al. (1989) · PubMed · Cited by 65

Endothelial Cell Regulation of Pulmonary Vascular Tone, Inflammation, and Coagulation

Goldenberg, N. M., & Kuebler, W. M. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140024 · Cited by 63

Effect of Carvedilol and Nebivolol on Oxidative Stress‐related Parameters and Endothelial Function in Patients with Essential Hypertension

Zepeda, R. J., Castillo, R. L., Rodrigo, R., Prieto, J. C., Aramburu, I., Brugère, S., Galdames, K., Noriega, V., & Miranda, H. F. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00911.x · Cited by 63

Angiotensin-(1–7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats

Costa, M. A., Verrilli, M. A. L., Gómez, K. A., Nakagawa, P., Peña, C., Arranz, C. T., & Gironacci, M. M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00850.2009 · Cited by 61

Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation

Ouweneel, A. B., & Eck, M. V. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.10.009 · Cited by 60

Angiotensin II Receptor Blockers Improve Peripheral Endothelial Function: A Meta-Analysis of Randomized Controlled Trials

Li, S., Wu, Y., Yu, G., Xia, Q., & Xu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090217 · Cited by 58

1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats

Claudio Napoli, A., Salomone, S., Godfraind, T., Palinski, W., Capuzzi, D. M., Palumbo, G. A., D’Armiento, F. P., Donzelli, R., de Nigris, F., Capizzi, R. L., et al. (1999) · Stroke · doi:10.1161/01.str.30.9.1907 · Cited by 57

Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence

Masuyer, G., Yates, C. J., Sturrock, E. D., & Acharya, K. R. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0157 · Cited by 57

Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis

Prasad, A., Halcox, J., Waclawiw, M. A., & Quyyumi, A. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01511-x · Cited by 56

Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA).

Siervo, M., Corander, M., Stranges, S., & Bluck, L. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.003 · Cited by 55

Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease

Παπαγεωργίου, Ν., Androulakis, E. S., Papaioannou, S., Antoniades, C. A., & Tousoulis, D. (2015) · Amino Acids · doi:10.1007/s00726-015-2017-y · Cited by 55

Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat

Spence, S. (1999) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00064-1 · Cited by 55

Endothelium-Derived Vasoactive Substances

Lüscher, T. F., Yang, Z., Diederich, D. A., et al. (1989) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198906146-00014 · Cited by 55

Oxidative stress in white coat hypertension; role of paraoxonase

Uzun, H., Karter, Y., Aydın, S., Çurgunlu, A., Şimşek, G., Yücel, R., Vehiyd, S., Ertürk, N. T., Kutlu, A., Benian, A., et al. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001697 · Cited by 53

Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin‐1‐induced vasoconstriction via ETA receptors and ERK

Kobayashi, T., Nogami, T., Taguchi, K., Matsumoto, T., & Kamata, K. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.327 · Cited by 50

Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis

Cuspidi, C., Sala, C., Tadic, M. V., Rescaldani, M., Grassi, G. M., & Mancia, G. (2014) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000094 · Cited by 48

Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension

Chaumais, M., Guignabert, C., Savale, L., Jaïs, X., Boucly, A., Montani, D., Simonneau, G., Humbert, M. J. C., & Sitbon, O. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0095-y · Cited by 47

Plasma Leptin and its Relationship with Lipid Peroxidation and Nitric Oxide in Obese Female Patients with or without Hypertension

Konukoğlu, D., Serin, O., & Turhan, M. S. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.12.002 · Cited by 43

Noninvasive Study of Endothelial Function in White Coat Hypertension

Gómez-Cerezo, J. F., Blanco, J. J. R., Suárez‐García, I., Anaya, P. M., García‐Raya, P., Muñoz, E. V., & Hernández, F. J. B. (2002) · Hypertension · doi:10.1161/01.hyp.0000030198.48441.65 · Cited by 41

The discovery of endothelium-dependent contraction: The legacy of Paul M. Vanhoutte

Barton, M. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.013 · Cited by 39

The impact of third-generation Beta-blocker antihypertensive treatment on endothelial function and the prothrombotic stateEffects of smoking

Vyssoulis, G. P. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.03.668 · Cited by 38

Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension

Çurgunlu, A., Uzun, H., Bavunoğlu, I., Karter, Y., Genç, H., & Vehid, S. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001867 · Cited by 34

Immune Mechanisms in Hypertension

Ciuceis, C. D., Rossini, C., Boria, E. L., Porteri, E., Petroboni, B., Gavazzi, A., Sarkar, A., Rosei, E. A., & Rizzoni, D. (2014) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-014-0040-9 · Cited by 33

Carvedilol‐Lisinopril Combination Therapy and Endothelial Function in Obese Individuals With Hypertension

Kelly, A. S., González-Campoy, J. M., Rudser, K. D., Katz, H., Metzig, A. M., Thalin, M., & Bank, A. J. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00569.x · Cited by 32

“White coat hypertension” in adolescents: Increased values of urinary cortisol and endothelin

Vaindirlis, I. N., Peppa-Patrikiou, M., Dracopoulou, M., Manoli, I., Voutetakis, A., & Dacou‐Voutetakis, C. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.103410 · Cited by 31

Oxidative stress in human in sustained and white coat hypertension

Caner, M., Karter, Y., Uzun, H., Çurgunlu, A., Vehid, S., Balci, H., Yücel, R., Güner, İ., KUTLU, A., Yaldıran, A., et al. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00959.x · Cited by 30

Circulating homocysteine levels in sustained and white coat hypertension

Pierdomenico, S. D., Bucci, A., Lapenna, D., Lattanzio, F., Talone, L., Cuccurullo, F., & Mezzetti, A. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001524 · Cited by 28

Immunity in arterial hypertension: associations or causalities?

Anders, H., Baumann, M., Tripepi, G. L., & Mallamaci, F. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv057 · Cited by 28

Dihydropyridine calcium channel blockers inhibit non-esterified-fatty-acid-induced endothelial and rheological dysfunction

Yasu, T., Kobayashi, M., Mutoh, A., Yamakawa, K., Momomura, S., & Ueda, S. (2013) · Clinical Science · doi:10.1042/cs20120311 · Cited by 27

Endothelial Dysfunction in Hypertension

Kiowski, W. (1999) · Clinical and Experimental Hypertension · doi:10.3109/10641969909060995 · Cited by 27

Endothelin-1 exacerbates development of hypertension and atherosclerosis in modest insulin resistant syndrome

Lin, Y., Juan, C., Kwok, C., Hsu, Y.-P., Shih, K., Chen, C., & Ho, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.017 · Cited by 26

Hemodynamics in White Coat Hypertension Compared to Ambulatory Hypertension and Normotension*

Soma, J., Aakhus, S., Dahl, K. J., Slørdahl, S. A., Wiseth, R., & Widerøe, T. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00203-8 · Cited by 23

Comparing the Effects of White Coat Hypertension and Sustained Hypertension on Mortality in a UK Primary Care Setting

Dawes, M. G., Bartlett, G., Coats, A. J. S., & Juszczak, E. (2008) · The Annals of Family Medicine · doi:10.1370/afm.865 · Cited by 22

Significance of microvascular remodelling for the vascular flow reserve in hypertension

Jacobsen, J. C., Hornbech, M. S., & Holstein‐Rathlou, N. (2010) · Interface Focus · doi:10.1098/rsfs.2010.0003 · Cited by 21

Hypertension and hemostatic/fibrinolytic balance disorders

Tabak, Ö., Gelışgen, R., Uzun, H., Kalender, B., Balci, H., Çurgunlu, A., Şimşek, G., & Karter, Y. (2009) · Clinical and investigative medicine · doi:10.25011/cim.v32i6.10664 · Cited by 20

Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension

Yavuzer, H., Cengız, M., Yavuzer, S., Altıparmak, M. R., Korkmazer, B., Balci, H., Yaldıran, A., & Uzun, H. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.59 · Cited by 13

Effects of PPARγ Ligands on Vascular Tone

Salomone, S., & Drago, F. (2012) · Current Molecular Pharmacology · doi:10.2174/1874-470211205020282 · Cited by 12

Cardiovascular risk reduction in hypertension: angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?

Sindone, A. P., Erlich, J., Lee, C., Newman, H. H., SURANYI, M. G., & Roger, S. D. (2016) · Internal Medicine Journal · doi:10.1111/imj.12975 · Cited by 12

The impact of serum homocysteine on intima-media thickness in normotensive, white-coat and sustained hypertensive adolescents

Lengyel, S., Katona, Ë., Zatik, J., Molnár, C., Paragh, G., Fülesdi, B., & Páll, D. (2011) · Blood Pressure · doi:10.3109/08037051.2011.575577 · Cited by 10

Is There Any Correlation between Insulin Resistance and Nitrate Plasma Concentration in White Coat Hypertensive Patients?

Marchi-Alves, L. M., & Cárnio, E. C. (2009) · Cardiology Research and Practice · doi:10.4061/2009/376735 · Cited by 8

Function of Vascular Endothelium

Wilson, S. H., & Lerman, A. (2001) · Elsevier eBooks · doi:10.1016/b978-012656975-9/50029-8 · Cited by 6

Mechanisms underlying the association between periodontitis and atherosclerotic disease

Schenkein, H. A., Papapanou, P. N., Genco, R., & Sanz, M. (2020) · Periodontology 2000 · doi:10.1111/prd.12304 · Cited by 440

Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes

Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312

Vascular mechanotransduction

Davis, M. J., Earley, S., Li, Y.-S., & Chien, S. (2023) · Physiological Reviews · doi:10.1152/physrev.00053.2021 · Cited by 273

Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies

Das, D., Shruthi, N. R., Banerjee, A., Jothimani, G., Duttaroy, A. K., & Pathak, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1221438 · Cited by 90

Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies

Weichmann, F., & Rohdewald, P. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1389374 · Cited by 38